Study: Cognitex Improves Cognition

MIGDAL, IsraelCognitex, a leading cognitive brand by Life-Extension, which uses Enzymotec's Sharp-PS® GOLD and Sharp-GPC was assessed in a recent clinical trial in which 30 elderly volunteer were administered Cognitex for 12 weeks.

"Our study demonstrated in two weeks after commencing treatment, Cognitex improved cognitive abilities related to attention by 19 percent, memory by 17 percent, and complex activities of daily living by 20 percent, said Dr. Yael Richter, head of the cognitive research group of Enzymotec. These and other effects were both statistically and clinically significant and were maintained and in some cases even amplified, during the duration of the study. Initial results are being published in the October edition of Life Extension Magazine".